CTKB – cytek biosciences, inc. (US:NASDAQ)
Stock Stats
News
Cytek Biosciences (NASDAQ:CTKB) was given a new $6.00 price target on by analysts at Morgan Stanley.
Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth [Seeking Alpha]
Cytek Biosciences (CTKB): Evaluating Valuation After TIME's 2026 Growth Leaders Recognition and Recurring Revenue Momentum [Yahoo! Finance]
TIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026 [Yahoo! Finance]
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
Form 4 Cytek Biosciences, Inc. For: Nov 18 Filed by: Yan Ming
Form 4 Cytek Biosciences, Inc. For: Nov 18 Filed by: Busque Philippe
Form 4 Cytek Biosciences, Inc. For: Nov 18 Filed by: Barnett Valerie
Form 4 Cytek Biosciences, Inc. For: Nov 18 Filed by: McCombe William D.
Form 4 Cytek Biosciences, Inc. For: Nov 18 Filed by: Jiang Wenbin
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.